AMD: Action Required

It is startling to learn that there are over twice as many Americans living with age-related macular degeneration (AMD) as those with Alzheimer's disease (AD). Research shows that nearly 20 million individuals in the US, aged 40+, wake up each morning facing challenges related to some form of macular degeneration, compared to an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer's. Globally, the medical community worldwide is bracing for the next surge in AMD cases, with prevalence expected to affect approximately 288 million people by 2040. In the US alone, by age 75 roughly one in three people will develop some form of AMD, and one in four of those will progress to a vision-threatening, late-stage form of the disease.

In light of this disparity, pro-active advocacy efforts are needed to influence policies and secure necessary resources to expand early AMD detection, improve patient outcomes, and enhance the quality of life for those affected.

 Read the Full Article 

 Want to learn more? Read the full article here.